Altasciences_Gradient_V_RGB.png
Le Dr Joseph A. Francisco nommé toxicologue en chef chez Altasciences
June 23, 2020 11:26 ET | ALTASCIENCES Company Inc.
LAVAL, Québec, 23 juin 2020 (GLOBE NEWSWIRE) -- Altasciences a annoncé aujourd'hui la nomination du Dr Joseph A. Francisco au poste de toxicologue en chef, à compter du 22 juin 2020. Le Dr...
Altasciences_Gradient_V_RGB.png
Joseph A. Francisco博士被任命为Altasciences首席毒物学家
June 23, 2020 11:26 ET | Altasciences Company Inc.
魁北克康华, June 23, 2020 (GLOBE NEWSWIRE) -- Altasciences今天宣布任命Joseph A. Francisco博士为首席毒物学家,自2020年6月22日起就任。 ...
Altasciences_Gradient_V_RGB.png
Dr. Joseph A. Francisco Appointed Chief Toxicologist at Altasciences
June 22, 2020 09:19 ET | Altasciences Company Inc.
LAVAL, Quebec, June 22, 2020 (GLOBE NEWSWIRE) -- Altasciences announced today the appointment of Dr. Joseph A. Francisco as Chief Toxicologist, effective June 22, 2020. Dr. Francisco is a...
Altasciences_Gradient_V_RGB.png
Dr. Gaetano Morelli Named Chief Medical Officer at Altasciences
June 09, 2020 07:00 ET | Altasciences Company Inc.
LAVAL, Quebec, June 09, 2020 (GLOBE NEWSWIRE) -- Altasciences announced today the appointment of Dr. Gaetano Morelli as Chief Medical Officer, effective May 14, 2020. Dr. Morelli is a member of the...
Altasciences_Gradient_V_RGB.png
Gaetano Morelli博士被任命为Altasciences首席医疗官
June 09, 2020 07:00 ET | Altasciences Company Inc.
魁北克拉瓦勒, June 09, 2020 (GLOBE NEWSWIRE) -- Altasciences今天宣布,任命Gaetano Morelli博士为首席医疗官,2020年5月14日起生效。 ...
Altasciences_Gradient_V_RGB.png
Altasciences完成Gimsilumab用于新冠肺炎(COVID-19)患者ARDS的一期研究
March 28, 2020 06:57 ET | Altasciences Company Inc.
魁北克拉瓦尔, March 28, 2020 (GLOBE NEWSWIRE) --...
Altasciences_Gradient_V_RGB.png
Altasciences Completes Phase I Study on Gimsilumab for ARDS in COVID-19
March 27, 2020 13:48 ET | Altasciences Company Inc.
LAVAL, Quebec, March 27, 2020 (GLOBE NEWSWIRE) -- Altasciences has completed a Phase I study for the development of gimsilumab, a fully human monoclonal antibody that targets granulocyte-macrophage...
Altasciences_Gradient_V_RGB.png
Altasciences和Amador Bioscience宣布进行战略合作
March 18, 2020 09:20 ET | Altasciences Company Inc.
魁北克省拉瓦勒, March 18, 2020 (GLOBE NEWSWIRE) -- 专门从事以灵活创新方式进行全面早期药品开发的美国及加拿大CRO(委托研究机构)Altasciences今天宣布,该机构已与位于中国及美国的转化及咨询临床研究机构Amador Bioscience签署合作协议。这一合作伙伴关系旨在扩大世界级的能力和资源,促进中国和北美的药物研发。 “我们为能与Amador...
Altasciences_Gradient_V_RGB.png
Altasciences and Amador Bioscience Announce Strategic Collaboration
March 17, 2020 09:17 ET | Altasciences Company Inc.
LAVAL, Quebec, March 17, 2020 (GLOBE NEWSWIRE) -- Altasciences, a CRO in the U.S. and Canada specializing in a flexible, innovative approach to comprehensive early stage drug development, announced...
Altasciences_Gradient_V_RGB.png
Paul Sidney加入Altasciences,担任合规与监管事务高级总监
January 10, 2020 10:00 ET | Altasciences Company Inc.
魁北克省拉瓦尔, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Altasciences宣布Paul Sidney加入其合规与法规事务团队,担任高级总监。Paul在Charles River Laboratories工作的丰富经验,加上他直接参与各种关键监管计划的经验,使他在药物开发领域的的制药公司、CRO和监管代表中受到高度赞誉。 ...